Advisory Board Members
In addition to the exceptional International Lifescience Enterprises staff, we have organized a Board of Advisers that support our mission to help life science businesses enter and/or start-up in the United States — and help U.S. life science operations extend their reach around the world. The board consults with the partners of ILE and will, as necessary, be introduced to key ILE clients and supported organizations.
The Board is comprised of scientists and PhD’s from the many life science disciplines we deal with. Those Board members with political backgrounds will assist in navigating the regulatory channels that are required for life science industry companies.
The quality advisory team for ILE supports our goals and objectives — which is oriented around making your life science businesses thrive and prosper in the U.S. and beyond.
R. Don Keysser, CM&AA
Don has over 30 years experience as an investment banker and business finance consultant, serving as Managing Director at the (former) Dain Rauscher for 13 years and Senior Vice President and Principal at Miller & Schroeder Financial for 3 years. He has been involved as senior banker on over $2.5 billion of financings.
Currently he provides business finance consulting services and corporate and project financing services, through his consulting firm, Hannover Ltd., working primarily with small to medium size privately held companies, in various technology sectors. This group provides a range of business finance consulting services (including business planning, financial analysis, turnaround management, international business expansion, M&A, interim CFO services, and expert witness services). Hannover has a joint-venture relationship with Auxilium Expat Business Services for working with US firms entering the EU market and EU firms entering the US market.
Don has an MA in Urban Planning and an MBA in Finance, both from the University of Minnesota, and is the final stages of finishing his doctorate degree in International Business. He is an Adjunct Professor of Finance in the MBA program at Argosy University, teaching classes in Capital Markets, Global Finance, Corporate Finance and Government Finance. He has been a guest lecturer at the University of Minnesota (Carlson School of Management), St. Thomas University, Wright State University, Metro State University and Hibbing College. He has the Series 7, 79, 28 and 63 securities licenses.
Don is a member of the Alliance of Merger & Acquisition Advisors (and CM&AA certified), the Association of Corporate Growth, and the American Council on Germany. He is on the Board of Directors of the Carlson School alumni, German-American Chamber of Commerce, and Moto-I (the only sake brew pub in North America). He is an active mentor in the Minnesota Cup business plan competition, in the Clean-Tech Open business plan competition, and at Carlson School.
Dr. Scandurra, CEO founded Aria CV, Inc. in 2010 to develop and commercialize the first medical device for treating pulmonary hypertension and right heart failure. Dr. Scandurra previously served as a Senior Fellow in the Medical Devices Center at the University of Minnesota, where he and his team invented Aria’s core technology. Dr. Scandurra received his Doctor of Veterinary Medicine degree from University of Wisconsin and obtained postdoctoral clinical training in veterinary cardiology from the University of Sydney. Dr. Scandurra also has Bachelor’s and Master’s degrees in Mechanical Engineering.
Laura Scandurra is a Foreign Service Officer with achievements in international regulatory and government affairs, agriculture, advocacy, strategic planning, trade policy and management. Over 20 years of state and federal government experience working in Wisconsin and Washington DC and U.S. Embassies in Europe, China, Japan, and New Zealand. Advanced degree from the University of Missouri-Columbia. Studied Japanese at Sophia University in Tokyo, Japan and Mandarin Chinese at the U.S. Embassy in Beijing, China.
Since 1985 Mr. McAllister has managed an international management advisory consulting practice serving high-technology, entrepreneurial corporations in the biotechnology, life science research, human and veterinary diagnostic, vaccine, regenerative medicine, device, pharmaceutical, and allied industries
Educated at Grove City College, Grove City, Pennsylvania, and The Pennsylvania State University, University Park, PA, where he obtained degrees in the biological sciences
After gaining his early quality control experience with several Fortune 500 companies, for over 20 years Mr. McAllister held increasing level management positions in manufacturing and quality with Abbott Laboratories’ Ross laboratories and Diagnostics Divisions, Amersham Corporation, Coulter Electronics Corporation, and lastly served as Vice President, Worldwide Quality Assurance for the Ares-Serono Group of Geneva, Switzerland and Boston, Massachusetts, with operations in over a dozen countries.
Mr. McAllister has senior management experience in quality assurance and control, regulatory and clinical affairs, manufacturing and materials management, and general management experience in personnel selection and organizational development, technology, product and company acquisition and divestiture, establishing distributorships, negotiating supply contracts and extramural research agreements, and intellectual property management, including patents and trademarks.
Mr. McAllister’s particular expertise lies in his ability to energize and lead organizations to move new products through the R&D pipeline to manufacturing for timely new product launch, always ensuring full regulatory compliance.
He has traveled widely, operating effectively in more than 50 countries, and is knowledgeable within the biologics, pharmaceutical, cellular therapy, medical device, including combination products, and allied industries. His experience covers a wide range of products, including innovative biopharmaceuticals, e.g., well-characterized proteins and polypedtides, their derivatives, and products of which they are components; and which have been isolated from body tissues and fluids, cell cultures, or produced using recombinant deoxyribonucleic acid (r-DNA) technology. This includes work with many of the cytokines (interferons, interlukins, colony-stimulating factors, tumor necrosis factors), erythropoeitin, plasminogen activator, blood plasma factors, growth hormones and growth factors, monoclonal antibodies, and vaccines. Additionally, he has worked with products such as whole blood, cellular components, as well as vitamins, minerals, and herbals. His experience also includes small molecules, combination devices, genomic testing (human genetic analysis) for clinical trials optimization, nuclear imaging drugs and medical imaging equipment and many new devices.
Mr. McAllister personally provides ad hoc and ad interim management services high tech biotech, drug and device companies. His success in preparing these organizations for pre-approval inspections by the U.S. FDA, EU EMA, and other world health regulatory authorities is unprecedented in the industry.
He is expert in providing mock FDA audit services, providing guidance in facility layout and design, quality system development, and personnel training.
He is a member of the PDA (Parenteral Drug Association), ASQ (American Society for Quality), and RAPS (Regulatory Affairs Professionals Society).
Thomas W. LaSalle
Thomas LaSalle is President and CEO of LaSalle Group, Ltd. Mr. LaSalle has forty years development, financing, consulting and management experience acquired primarily through his three privately-held corporations – LaSalle Management Group, Ltd. and LaSalle Development Group, Ltd.
Active in the industry and community, Mr. LaSalle is past president of the Minnesota Multi-Housing Association and served as a director of the National Apartment Association and the Institute of Real Estate Management. He is a licensed Certified Property Manager and licensed real estate broker in Minnesota and Illinois. Mr. LaSalle has served on the Board of the Drake Bank, is immediate Past President of the University of Minnesota Alumni Association, is past Chair of Gateway Corporation, past Chair of the University YMCA, past Chair of Sobriety High School, and is on the board of the Aquatennial Ambassador Organization. Mr. LaSalle is a Professor in Practice at the University of Minnesota.
Douglas W. Freitag
Douglas W. Freitag brings 30 years of expertise in Federal Business Development. He formed Bayside Materials Technology (BMT) in 1993 after a successful career in various management and engineering roles while employed by Lockheed Martin, Honeywell, and Ford Motor Company. BMT was formed to support academia, investors and industry with the process of identifying, creating and commercializing new technologies where the Federal Government plays a role, either as an investor, regulator or user. BMT routinely works with all aspects of the Federal Government in areas of a policy, regulatory, procurement, or R&D funding nature. Technologies/markets served include advanced materials, electronics, optics, lifesciences, biotech, transportation, industrial processing, infrastructure, power & energy, water, defense, etc. Mr. Freitag has a technical background with a B.S. and M.S. in Mechanical Engineering from Purdue University. Prior to forming BMT, Mr. Freitag published and presented over sixty papers in advanced materials, was issued several patents, organized and chaired numerous technical sessions at national meetings, and participated in various government panels in support of the advanced materials industry. He currently serves as the Technical Director for the US Advanced Ceramics Association and holds a Secret level DOD clearance. BMT is located in Columbia, MD.
Shaye Mandle has served as the President & CEO for LifeScience Alley since May 1, 2014. Previously, Mr. Mandle served as the association’s Executive Vice President & COO and was responsible for aligning internal operations with organizational strategy and overseeing advocacy efforts and key external relationships. Prior to serving as Executive Vice President & COO, Mr. Mandle served as the association’s Vice President of Government & Affiliate Relations.
Mr. Mandle has nearly 20 years of experience in government, the private sector and academia, leading organizations, public affairs and political activities. Prior to joining LifeScience Alley, Mr. Mandle served as the Executive Director of the FedEx Institute of Technology at the University of Memphis, where he launched and oversaw the University Office of Technology Transfer and led the University’s corporate partnership, entrepreneurship and economic development programming. Mr. Mandle has also led business development and government affairs for the Reconnaissance and Surveillance Operation of Science Applications International Corporation (SAIC), a Fortune 500 company specializing in defense and homeland security technologies.
Mr. Mandle has served as the chief executive of two industry and economic development organizations, the East-West Corporate Corridor Association and the Illinois Coalition. He has extensive policy and political experience, having managed state and federal campaigns and having served on the policy staff of former U.S. House Speaker J. Dennis Hastert and former Illinois Governor Jim Edgar. Mr. Mandle has a Juris Doctor, cum laude, from the Duquesne University Law School and a Bachelor of Arts from Illinois Wesleyan University.